Pfizer's Blockbuster Hopeful Can't Win in Europe

Pfizer (NYSE: PFE  ) investors have cheered the stock's remarkable gains this year, but the company's performance in the shadow of major patent expirations has been remarkable. New drugs have risen to supplant the firm's old blockbusters, and rheumatoid arthritis drug Xeljanz, approved by the Food and Drug Administration last year, has led the charge as one of tomorrow's most promising therapies.

Unfortunately, European regulators didn't feel the same way. Late last week, Europe's Committee for Medicinal Products for Human Use, or CHMP, recommended that Xeljanz not be approved to treat rheumatoid arthritis across the Atlantic. Should you be worried about Xeljanz's failure in Europe? Motley Fool contributor Dan Carroll and health care analyst Max Macaluso tell you what you need to know in the video below.

Pfizer missed a chance to capture of Europe's rheumatoid arthritis market with Xeljanz, but it's still looking up to the biggest immunology drug on the market: AbbVie's Humira. However, is AbbVie safe, with this blockbuster making up a huge portion of its total sales? The Fool's brand new premium report on the company answers the high-profile questions that AbbVie investors are asking. Simply click here now to claim your copy today.


Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2396937, ~/Articles/ArticleHandler.aspx, 9/2/2014 1:41:32 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement